Clinical Animal Stemcell Research Inc.

  • HOME »
  • Profile »
  • Clinical Animal Stemcell Research Inc.


We inform the world on innovative regenerative medicines and treatment methods for animals.
These therapies using DFAT super cells are revolutionary treatments and therapeutic drugs which minimize the decline of physical fitness in animals.
Regenerative medicine for animals with DFAT!

Company Profile

Company Name Clinical Animal Stemcell Research Inc.
Headquarters Address 1-11-4 Hiroo, Shibuya, Tokyo
Executives Representative Director:Ryuji Sugawara
Director:Takaaki Tokunaga
Capital Stock 2,000,000 yen
Activities Regenerative medicine for animals, product development
Primary Bank MUFG Bank

DFAT cells were used Treatment for small animals

Regenerative medicine What is DFAT cell?

What is DFAT-derived supernatant?

Copyright © Stemcell Holdings Limited. All Rights Reserved.
Powered by WordPress & BizVektor Theme by Vektor,Inc. technology.